Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vi capsular polysaccharide (Vi antigen) is a surface-expressed linear polymer found on *Salmonella enterica* serovar Typhi. It is a major virulence factor that enables the bacterium to evade host immune responses and establish infection. It confers resistance to phagocytosis and complement-mediated killing, and suppresses inflammatory responses. Purified Vi polysaccharide forms the basis for licensed vaccines against typhoid fever.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vi Capsular Polysaccharide of Salmonella Typhi (Vi antigen).